Neuroscientists at Virginia Tech’s Fralin Biomedical Research Institute at VTC will investigate how obesity influences brain ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at certain dosages.

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Diabetes mellitus is most commonly known as diabetes, which is a disease that affects how the body uses glucose or blood ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Studies have also shown that sweeteners can stimulate the same neurons as the appetite hormone, leptin. Over time, this could ...

Medical tests have now revealed she died due to complications from diabetes. We examine the different types of diabetes, the ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Get expert tips on food safety, including proper food handling, storage, and preparation practices to prevent foodborne ...